Experts project the diagnosis of over 300,000 prostate cancer cases in the United States in 2006, along with over 30,000 ...

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...

Thousands of people living with advanced prostate cancer will have access to a life-extending new treatment that can be taken at home from today (Friday, 23 January). NICE has recommended talazoparib ...

From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...

Advanced prostate cancer cases are rising worldwide as fewer men undergo routine PSA screening and early symptoms go ...

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

North East patients are among the first in the UK to trial Lutetium (177Lu) rhPSMA-10.1, a new targeted treatment for advanced prostate cancer resistant to hormone therapy.

A new drug combo is offering hope for men with advanced prostate cancer. Adding the targeted cancer drug niraparib to hormone therapy reduced the risk of prostate tumor growth and slowed symptom ...

From today, Australians with an aggressive form of prostate cancer will have access to cheaper medicines on the Pharmaceutical Benefits Scheme ...

Former President Joe Biden's advanced prostate cancer diagnosis has left Fox News senior medical analyst Dr. Marc Siegel "absolutely shocked" by the timing. "It has to get really pretty far advanced ...